0000874015-23-000118.txt : 20230324 0000874015-23-000118.hdr.sgml : 20230324 20230324190321 ACCESSION NUMBER: 0000874015-23-000118 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230314 FILED AS OF DATE: 20230324 DATE AS OF CHANGE: 20230324 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Birchler Brian CENTRAL INDEX KEY: 0001970151 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 23761141 MAIL ADDRESS: STREET 1: C/O IONIS PHARMACEUTICALS, INC. STREET 2: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 3 1 edgardoc.xml PRIMARY DOCUMENT X0206 3 2023-03-14 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001970151 Birchler Brian 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 EVP, Corp and Development Ops Common Stock 35325 D Non-Qualified Stock Option (right to buy) 32.6 2032-01-02 Common Stock 19500 D Non-Qualified Stock Option (right to buy) 35.25 2032-03-19 Common Stock 15000 D Non-Qualified Stock Option (right to buy) 37.58 2033-01-02 Common Stock 22942 D Non-Qualified Stock Option (right to buy) 47.34 2024-01-02 Common Stock 26982 D Non-Qualified Stock Option (right to buy) 49.25 2025-01-01 Common Stock 31500 D Non-Qualified Stock Option (right to buy) 53.77 2026-01-01 Common Stock 23900 D Non-Qualified Stock Option (right to buy) 56.78 2028-01-03 Common Stock 22000 D Non-Qualified Stock Option (right to buy) 60.89 2027-01-01 Common Stock 26063 D Non-Qualified Stock Option (right to buy) 61.57 2024-01-01 Common Stock 15500 D Performance Restricted Stock Units 0.0 Common Stock 14338 D Restricted Stock Unit 0.0 2024-01-15 2024-01-15 Common Stock 2896 D Restricted Stock Unit 0.0 2024-01-15 2025-01-15 Common Stock 4888 D Restricted Stock Unit 0.0 2024-01-15 2026-01-15 Common Stock 7312 D Restricted Stock Unit 0.0 2023-04-15 2026-04-15 Common Stock 7500 D Restricted Stock Unit 0.0 2024-01-15 2027-01-15 Common Stock 17207 D Grant on 01/03/2022 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option will be vested and become exercisable on 01/03/2023. Thereafter, the remaining shares subject to the option vested and became exercisable in 36 equal monthly installments. The option is exercisable as to 5,687 shares on 03/14/2023. Grant on 03/20/2022 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option will be vested and become exercisable on 03/20/2023. Thereafter, the remaining shares subject to the option vested and became exercisable in 36 equal monthly installments. The option is exercisable as to 0 shares on 03/14/2023. Grant on 01/03/2023 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option will be vested and become exercisable on 01/03/2024. Thereafter, the remaining shares subject to the option vested and became exercisable in 36 equal monthly installments. The option is exercisable as to 0 shares on 03/14/2023. Grant on 01/03/2017 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option vested and became exercisable on 01/03/2018. Thereafter, the remaining shares subject to the option vested and became exercisable in 36 equal monthly installments. The option is exercisable as to 26,982 shares on 03/14/2023. Grant on 01/02/2018 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option vested and became exercisable on 01/02/2019. Thereafter, the remaining shares subject to the option vested and became exercisable in 36 equal monthly installments. The option is exercisable as to 31,500 shares on 03/14/2023. Grant on 01/02/2019 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option vested and became exercisable on 01/02/2020. Thereafter, the remaining shares subject to the option vested and became exercisable in 36 equal monthly installments. The option is exercisable as to 23,900 shares on 03/14/2023. Grant on 01/04/2021 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option will be vested and become exercisable on 01/04/2022. Thereafter, the remaining shares subject to the option vested and became exercisable in 36 equal monthly installments. The option is exercisable as to 11,916 shares on 03/14/2023. Grant on 01/02/2020 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option will be vested and become exercisable on 01/02/2021. Thereafter, the remaining shares subject to the option vested and became exercisable in 36 equal monthly installments. The option is exercisable as to 20,633 shares on 03/14/2023. Grant on 01/02/2015 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. 25% of the shares subject to the option vested and became exercisable on 01/02/2016. Thereafter, the remaining shares subject to the option vested and became exercisable in 36 equal monthly installments. The option is exercisable as to 15,500 shares on 03/14/2023 Grant to reporting person of Performance Restricted Stock Units under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Represents an award of performance based restricted stock units ("PRSUs"). The PRSUs may vest at the end of the three-year performance period following the date of grant based on the Issuer's relative total shareholder return as compared to a peer group of companies. The number of PRSUs reported represents the maximum that may be earned, which is 200% of the target number. No number of PRSUs is guaranteed to vest and the actual number of PRSUs that will vest at the end of the performance period may be anywhere from zero to the amount stated. Each restricted stock unit represents a contingent right to receive one share of Isis common stock, or its equivalent cash value. The restricted stock units vest in four equal annual installments, the first installment vesting on January 15, 2021. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2024. The restricted stock units vest in four equal annual installments, the first installment vesting on January 15, 2022. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2025. The restricted stock units vest in four equal annual installments, the first installment vesting on January 15, 2023. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2026. The restricted stock units vest in four equal annual installments, the first installment vesting on April 15, 2022. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on April 15, 2026. The restricted stock units vest in four equal annual installments, the first installment vesting on January 15, 2023. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2027. By: Patrick R. O'Neil, attorney-in-fact For: Brian Birchler 2023-03-24